Biofrontera Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biofrontera Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Biofrontera Inc. Return On Equity for the quarter ending September 30, 2024 was -325 %, a 49.9% decline year-over-year.
  • Biofrontera Inc. annual Return On Equity for 2023 was -271 %, a 8476% decline from 2022.
  • Biofrontera Inc. annual Return On Equity for 2022 was -3.16 %, a 100% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -325 -108 -49.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -477 -348 -270% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.22K -1.15K -1690% Jan 1, 2024 Mar 31, 2024
Q4 2023 -271 -267 -8476% Oct 1, 2023 Dec 31, 2023
Q3 2023 -217 -144 -200% Jul 1, 2023 Sep 30, 2023
Q2 2023 -129 +232 +64.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -68 +1.08K +94.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.16 -2.95K -100% Oct 1, 2022 Dec 31, 2022
Q3 2022 -72.1 Jul 1, 2022 Sep 30, 2022
Q2 2022 -361 Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.14K Jan 1, 2022 Mar 31, 2022
Q4 2021 2.95K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.